Express Scripts Holding Co (ESRX.OQ)
16 Sep 2014
|Market Cap (Mil.):||$54,965.75|
|Shares Outstanding (Mil.):||745.45|
COPENHAGEN - Novo Nordisk <NOVOb.CO said on Thursday it could launch its new long-acting insulin Tresiba, a crucial future growth driver for the Danish company, at the start of 2016 in the United States.
* Shares up 1.5 pct (Adds comments from CEO, analysts, share price)
* Move may boost use but prices still seen under pressure
LONDON - GlaxoSmithKline (GSK) received a boost on Monday from a decision by Express Scripts, the largest U.S. pharmacy benefit manager, to reinstate its top-selling lung drug Advair as an approved drug in 2015.
Aug 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said on Friday it will remove an additional 25 products from its list of preferred drugs in 2015, including anemia drugs Epogen and Aranesp, sold by Amgen Inc.
- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc.
Aug 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will not include anemia drugs Epogen and Aranesp, both sold by Amgen Inc, on its 2015 list of preferred medications.
July 29 - Express Scripts Holding Co, the largest pharmacy benefits manager in North America, posted a weaker profit and narrowed its full year forecast.
(The following statement was released by the rating agency) CHICAGO, June 02 (Fitch) Fitch Ratings has assigned a 'BBB' rating to the proposed senior unsecured bond issuance by Express Scripts Holding Company (NYSE:ESRX). Proceeds from the issuance are expected to be used for the redemption of ESRX's $900 million and $1.25 billion of unsecured bonds due November 2014 and November 2016, respectively, and for general corporate purposes (including some share repurchase). Fitch currently rates
THOMSON REUTERS, May 06,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (ESRX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Wright Reports
Provider: S&P Capital IQ – STARS Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.